Danaher Corp (DHR) - Biotechnology Operating Income (I:DCDHRBOI)
Level Chart
Basic Info
|
Danaher Corp (DHR) - Biotechnology Operating Income is at a current level of 477.00M, down from 556.00M last quarter and down from 531.00M one year ago. This is a change of -14.21% from last quarter and -10.17% from one year ago. |
|
Danaher Corp Biotechnology Operating Income refers to the profit or earnings derived from the specific business segment that focuses on providing biotechnology solutions and products within Danaher Corporation. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 477.00M |
| Latest Period | Sep 2026 |
| Last Updated | Oct 21 2026, 09:16 EDT |
| Next Release | Jan 27 2027, 08:30 EST (E) |
| Average Growth Rate | -1.36% |
| Value from Last Quarter | 556.00M |
| Change from Last Quarter | -14.21% |
| Value from 1 Year Ago | 531.00M |
| Change from 1 Year Ago | -10.17% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File |
Historical Data
| Date | Value |
|---|---|
| September 25, 2026 | 477.00M |
| June 26, 2026 | 556.00M |
| March 27, 2026 | 534.00M |
| December 31, 2025 | 540.00M |
| September 26, 2025 | 352.00M |
| June 27, 2025 | 531.00M |
| March 28, 2025 | 441.00M |
| December 31, 2024 | 508.00M |
| September 27, 2024 | 390.00M |
| June 28, 2024 | 462.00M |
| March 29, 2024 | 325.00M |
| December 31, 2023 | 416.00M |
| September 29, 2023 | 417.00M |
| June 30, 2023 | 480.00M |
| Date | Value |
|---|---|
| March 31, 2023 | 596.00M |
| December 31, 2022 | 693.00M |
| September 30, 2022 | 691.00M |
| July 01, 2022 | 824.00M |
| April 01, 2022 | 800.00M |
| December 31, 2021 | 780.00M |
| October 01, 2021 | 0.00 |
| July 02, 2021 | 0.00 |
| April 02, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| October 02, 2020 | 0.00 |
| July 03, 2020 | 0.00 |
| April 03, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
News
Basic Info
|
Danaher Corp (DHR) - Biotechnology Operating Income is at a current level of 477.00M, down from 556.00M last quarter and down from 531.00M one year ago. This is a change of -14.21% from last quarter and -10.17% from one year ago. |
|
Danaher Corp Biotechnology Operating Income refers to the profit or earnings derived from the specific business segment that focuses on providing biotechnology solutions and products within Danaher Corporation. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 477.00M |
| Latest Period | Sep 2026 |
| Last Updated | Oct 21 2026, 09:16 EDT |
| Next Release | Jan 27 2027, 08:30 EST (E) |
| Average Growth Rate | -1.36% |
| Value from Last Quarter | 556.00M |
| Change from Last Quarter | -14.21% |
| Value from 1 Year Ago | 531.00M |
| Change from 1 Year Ago | -10.17% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File |
Related Securities
Related Indicators
| Danaher Corp (DHR) - Former Life Sciences Revenue | 3.672B USD |
| Danaher Corp (DHR) - Life Sciences Operating Income | 259.00M USD |
| Danaher Corp (DHR) - Life Sciences Revenue | 1.865B USD |
| Danaher Corp (DHR) - Non-Recurring Revenue | 1.155B USD |
| Danaher Corp (DHR) - Recurring Revenue | 5.399B USD |